Melanoma in situ, unspecified is a localized skin cancer characterized by the uncontrolled growth of melanocytes, the pigment-producing cells in the skin. This condition is clinically significant as it can progress to invasive melanoma if not treated. The ICD-10 Code D03.9 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage cases of melanoma.
ICD-10 Code D03.9 represents Melanoma in situ, unspecified, indicating a non-invasive form of melanoma that has not yet penetrated deeper skin layers. This code should be used when documenting cases of melanoma that are localized and have not been classified further. It is essential for accurate clinical documentation and billing, ensuring appropriate treatment and follow-up.
Melanoma in situ, unspecified is a critical dermatological condition that arises from the proliferation of melanocytes within the epidermis. It is primarily caused by UV radiation exposure and can progress to invasive melanoma if left untreated. Prompt medical attention is necessary to prevent complications.
ICD-10 Code D03.9 is utilized in SOAP notes to document the presence of melanoma in situ, guiding clinical workflows. It plays a vital role in recording patient symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D03.9 connects subjective patient reports and objective clinical findings to a formal diagnosis of melanoma in situ. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Timely intervention for melanoma in situ is essential to prevent progression. Treatment typically involves surgical excision of the lesion.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D03.9 is essential for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 0.5 cm. |
| 11401 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter 0.6 to 1.0 cm. |
| 11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter up to 0.5 cm. |
| 11601 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter 0.6 to 1.0 cm. |
Common Questions About Using ICD-10 Code D03.9 for Melanoma in situ, unspecified
What are the risk factors for melanoma in situ?
Risk factors for melanoma in situ include excessive UV exposure, a history of sunburns, having many moles, and a family history of skin cancer. Regular skin checks are recommended for early detection.
How is melanoma in situ treated?
Melanoma in situ is primarily treated through surgical excision of the lesion. Follow-up care is essential to monitor for any recurrence or new lesions.
Is melanoma in situ contagious?
No, melanoma in situ is not contagious. It is a type of skin cancer that arises from genetic mutations in skin cells, primarily due to UV exposure.
How often should patients with melanoma in situ have follow-up appointments?
Patients with melanoma in situ should have follow-up appointments every 3 to 6 months for the first few years after treatment, then annually, to monitor for any new skin changes.
Clinical Notes
SOAP notes
DAP notes
AI medical notes